People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Accu-Break Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $1.5M | $23.7M | 2013 |
| Scion Cardio-Vascular, Inc. | — | Other Health Care | Pre-Seed | $200K | $6.2M | 2011 |
Robert I Goldfarb at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert I Goldfarb on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John M. Siebert | 1 | 4 |
| Mel E. Harris | 1 | 2 |
| Robert E. Baldini | 1 | 2 |
| John N Siebert | 1 | 1 |
| Nigel N Norton | 1 | 1 |
| David N Lucking | 1 | 1 |
| Robert N Baldini | 1 | 1 |
| David E. Lucking | 1 | 1 |
| Lloyd A. Moriber | 1 | 1 |
| Barry R Alter | 1 | 1 |
| Louis R Rose | 1 | 1 |
| James R Riegler | 1 | 1 |
| Lawrence A Garcia | 1 | 1 |
| Peter I Gurman | 1 | 1 |
| Elliot F Hahn | 1 | 1 |
| Mel N Harris | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.